Biotechnology company Provectus Biopharmaceuticals has entered into an option agreement with the University of Miami for the exclusive licensing of products developed by its Ophthalmic Biophysics Center of Bascom Palmer Eye Institute.
Provectus Biopharmaceuticals enters agreement with U of Miami
